Labcorp to Speak at the Baird 2024 Global Healthcare Conference
Rhea-AI Summary
Labcorp (NYSE: LH), a leading global provider of innovative laboratory services, has announced its participation in the Baird 2024 Global Healthcare Conference. Members of Labcorp's executive management team are scheduled to deliver a presentation on Tuesday, September 10, at 3:10 p.m. ET.
This event provides an opportunity for Labcorp to showcase its expertise and discuss industry trends with investors and healthcare professionals. The conference, organized by Baird, is a significant platform for companies in the healthcare sector to share insights and connect with stakeholders.
Labcorp's involvement in this conference underscores its position as a key player in the laboratory services industry and its commitment to engaging with the investment community.
Positive
- None.
Negative
- None.
News Market Reaction – LH
On the day this news was published, LH declined 0.71%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
About Labcorp
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's more than 67,000 employees serve clients in approximately 100 countries, provided support for
View original content to download multimedia:https://www.prnewswire.com/news-releases/labcorp-to-speak-at-the-baird-2024-global-healthcare-conference-302237190.html
SOURCE Labcorp Holdings Inc
FAQ
When is Labcorp (LH) presenting at the Baird 2024 Global Healthcare Conference?
Who will be representing Labcorp (LH) at the Baird 2024 Global Healthcare Conference?
What type of services does Labcorp (LH) provide?
Where is Labcorp (LH) headquartered?
